Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 1/20 | 0.35 |
| ▸ | BRAF | P15056 | 1/20 | 0.34 |
| ▸ | TEK | Q02763 | 1/20 | 0.34 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.33 |
| ▸ | MTOR | P42345 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | USP30 | Q70CQ3 | 2/20 | 0.32 |
| ▸ | PRKDC | P78527 | 1/20 | 0.32 |
| ▸ | ATR | Q13535 | 1/20 | 0.32 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20631699 | 0.91 | CYP11B2 (0.35) | CYP11B2BRAFTEKLRRK2MTOR | |
| SCHEMBL20633408 | 0.89 | CYP11B2 (0.35) | CYP11B2BRAFTEKLRRK2MTOR | |
| SCHEMBL20633345 | 0.88 | NPC1 (0.40) | CYP11B2BRAFTEKCNR1TP53 | |
| SCHEMBL20631494 | 0.87 | MET (0.37) | CYP11B2LRRK2MTORCNR1USP30 | |
| SCHEMBL20632576 | 0.84 | BRAF (0.35) | CYP11B2BRAFLRRK2MTORADORA2A | |
| SCHEMBL20631659 | 0.82 | GRIN1 (0.32) | CNR1 | |
| SCHEMBL20631471 | 0.82 | BCL6 (0.33) | CYP11B2TEKLRRK2MTORUSP30 | |
| SCHEMBL20633088 | 0.82 | GRM5 (0.42) | CYP11B2LRRK2ADORA2AUSP30 | |
| SCHEMBL20632984 | 0.82 | PRKD1 (0.36) | LRRK2MTORADORA2AUSP30HRH4 | |
| SCHEMBL20631643 | 0.79 | HTR2C (0.41) | TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2997029-B1 | SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS | GLAXOSMITHKLINE LLC (US) | 2019-01-09 | — | — | EP | disclosed |